DIFFERENTIAL UPTAKE OF IMMUNO-ONCOLOGY (IO) TREATMENTS AMONG DIFFERENT INCOME LEVELS FOR NON-SMALL CELL CANCER PATIENTS IN CHINA

被引：0
|
作者：
De Richter, P. [1 ]
机构：
[1] Ipsos, Kuala Lumpur 14, Malaysia
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN246
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [11] Expanding role for radiotherapy in metastatic non-small cell lung cancer in the era of targeted therapy and immuno-oncology
    Luterstein, Elaine
    Lee, Percy
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 60 - 63
  • [12] SYSTEMATIC LITERATURE REVIEW FOR TREATMENT OUTCOMES (INCLUDING IMMUNO-ONCOLOGY TREATMENT) AMONG PATIENTS WITH STAGE 3 UNRESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC)
    Zhou, Z.
    Song, J.
    Ouwens, M. J.
    Huhn, M.
    Jiang, H.
    Zhang, Y.
    Dalevi, D.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A416 - A416
  • [13] The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer
    Low, Jia Li
    Walsh, Robert J.
    Ang, Yvonne
    Chan, Gloria
    Soo, Ross A.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [14] Interprofessional care team practices and perspectives on immuno-oncology (IO) therapies for metastatic non-small cell lung cancer (mNSCLC): Insights from a nationwide survey.
    Farris, Breanne Y.
    Jacobson, Anne
    Carter, Jeffrey D.
    Heggen, Cherilyn
    Socinski, Mark A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [15] Hospitalizations and emergency department (ED) visits pre- and post-approval of immuno-oncology agents (IO) in advanced non-small cell lung cancer (aNSCLC).
    Radtchenko, Janna
    Korytowsky, Beata
    Nwokeji, Esmond
    Tuell, Ken
    Feinberg, Bruce A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [16] Understanding Total Cost of Care in Advanced Non-Small Cell Lung Cancer Pre- and Postapproval of Immuno-Oncology Therapies
    Korytowsky, Beata
    Radtchenko, Janna
    Nwokeji, Esmond D.
    Tuell, Kenneth W.
    Kish, Jonathan K.
    Feinberg, Bruce A.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (20): : S439 - S447
  • [17] Association of retinoblastoma function with response to immuno-oncology treatment in patients with small cell lung cancer
    Balli, David
    Wang, Xuya
    Rizvi, Naiyer A.
    Chan, Timothy A.
    Dowlati, Afshin
    Doshi, Parul
    Chang, Han
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [18] Transitional Cell Carcinoma plus non-small cell Lung Cancer PD-L1-Inhibitors: The next Generation in Immuno-oncology
    Freye, Reimund
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (12)
  • [19] Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer
    Heigener, David
    Reck, Martin
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 69 - 83
  • [20] Utilization of second-line immuno-oncology agents and associated health outcomes among united states veterans with advanced non-small cell lung cancer
    Allo, Mina
    Gu, Lin
    Vashistha, Vishal
    Press, Ashlyn
    Kelley, Michael
    Williams, Christina
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345